Where Will Applied Molecular Transport Inc. (AMTI) Stock Go Next After It Has Risen 47.65% in a Week?

Monday, February 22, 2021 10:10 AM | InvestorsObserver Analysts

Overall market sentiment has been high on Applied Molecular Transport Inc. (AMTI) stock lately. AMTI receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Applied Molecular Transport Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AMTI!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.

Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.

InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.

Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With AMTI Stock Today?

Applied Molecular Transport Inc. (AMTI) stock has risen 14.01% while the S&P 500 is lower by -0.51% as of 9:56 AM on Monday, Feb 22. AMTI has gained $9.03 from the previous closing price of $64.47 on volume of 9,527 shares. Over the past year the S&P 500 is higher by 21.69% while AMTI has gained 308.79%. AMTI lost -$1.43 per share in the over the last 12 months.

To see the top 5 stocks in the Biotechnology industry click here.

More About Applied Molecular Transport Inc.

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.

Click Here to get the full Stock Score Report on Applied Molecular Transport Inc. (AMTI) Stock.

Share this article:

Related Companies

You May Also Like

Related Articles

European Stocks Snap Winning Streak on Wednesday on Rising Bond Yields

Reata Pharmaceuticals Inc (RETA) Stock: What Does the Chart Say Wednesday?

Is Quidel Corporation (QDEL) a Stock to Watch After Losing -11.20% This Week?

Do Traders Think Nabriva Therapeutics PLC - ADR (NBRV) Can Turn Around Wednesday?

Related Companies